SILVERCREST ASSET MANAGEMENT GROUP LLC – Halozyme Therapeutics, Inc. Transaction History
SILVERCREST ASSET MANAGEMENT GROUP LLC portfolio value:
$17.34M
portfolio value
SILVERCREST ASSET MANAGEMENT GROUP LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +14.25% | 54.68K shares | 450K | $39.54 | 438.54K |
| Q2 2022 | share | Increase | +31.31% | 91.52K shares | 5.23M | $44 | 383.85K |
| Q1 2022 | share | Increase | +3237.84% | 283.57K shares | 11.30M | $39.88 | 292.32K |
| Q4 2021 | share | Increase | +11.17% | 880 shares | 32K | $40.32 | 8.75K |
| Q3 2021 | share | Increase | +13.19% | 918 shares | 4K | $40.68 | 7.87K |
| Q2 2021 | share | Increase | +2.02% | 138 shares | 32K | $45.41 | 6.96K |
| Q1 2021 | share | Increase | +3.35% | 221 shares | 2K | $41.69 | 6.82K |
| Q4 2020 | share | Increase | 0.00% | 6.60K shares | 282K | $42.71 | 6.60K |